全文获取类型
收费全文 | 2619篇 |
免费 | 262篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 84篇 |
妇产科学 | 46篇 |
基础医学 | 328篇 |
口腔科学 | 36篇 |
临床医学 | 320篇 |
内科学 | 489篇 |
皮肤病学 | 41篇 |
神经病学 | 172篇 |
特种医学 | 203篇 |
外科学 | 292篇 |
综合类 | 51篇 |
一般理论 | 3篇 |
预防医学 | 266篇 |
眼科学 | 134篇 |
药学 | 221篇 |
中国医学 | 4篇 |
肿瘤学 | 192篇 |
出版年
2022年 | 18篇 |
2021年 | 24篇 |
2020年 | 19篇 |
2019年 | 32篇 |
2018年 | 56篇 |
2017年 | 24篇 |
2016年 | 27篇 |
2015年 | 44篇 |
2014年 | 47篇 |
2013年 | 68篇 |
2012年 | 79篇 |
2011年 | 123篇 |
2010年 | 65篇 |
2009年 | 83篇 |
2008年 | 109篇 |
2007年 | 116篇 |
2006年 | 122篇 |
2005年 | 101篇 |
2004年 | 113篇 |
2003年 | 92篇 |
2002年 | 99篇 |
2001年 | 69篇 |
2000年 | 79篇 |
1999年 | 62篇 |
1998年 | 51篇 |
1997年 | 56篇 |
1996年 | 44篇 |
1995年 | 34篇 |
1994年 | 31篇 |
1993年 | 29篇 |
1992年 | 66篇 |
1991年 | 72篇 |
1990年 | 65篇 |
1989年 | 88篇 |
1988年 | 66篇 |
1987年 | 69篇 |
1986年 | 51篇 |
1985年 | 51篇 |
1984年 | 39篇 |
1983年 | 42篇 |
1982年 | 23篇 |
1981年 | 23篇 |
1980年 | 26篇 |
1979年 | 31篇 |
1978年 | 27篇 |
1977年 | 21篇 |
1976年 | 20篇 |
1975年 | 18篇 |
1974年 | 17篇 |
1973年 | 21篇 |
排序方式: 共有2904条查询结果,搜索用时 15 毫秒
1.
The human visual system is amenable to a number of adaptive processes; one such process, or collection of processes, is the adaptation to blur. Blur adaptation can be observed as an improvement in vision under degraded conditions, and these changes occur relatively rapidly following exposure to blur. The potential important future directions of this research area and the clinical implications of blur adaptation are discussed. 相似文献
2.
3.
Bill J Gurley Ashley Swain Gary W Barone D Keith Williams Philip Breen C Ryan Yates Leslie B Stuart Martha A Hubbard Yudong Tong Sreekhar Cheboyina 《Drug metabolism and disposition》2007,35(2):240-245
Phytochemical-mediated modulation of P-glycoprotein (P-gp) and other drug transporters may give rise to many herb-drug interactions. Serial plasma concentration-time profiles of the P-gp substrate, digoxin, were used to determine whether supplementation with goldenseal or kava kava modified P-gp activity in vivo. Twenty healthy volunteers were randomly assigned to receive a standardized goldenseal (3210 mg daily) or kava kava (1227 mg daily) supplement for 14 days, followed by a 30-day washout period. Subjects were also randomized to receive rifampin (600 mg daily, 7 days) and clarithromycin (1000 mg daily, 7 days) as positive controls for P-gp induction and inhibition, respectively. Digoxin (Lanoxin, 0.5 mg) was administered p.o. before and at the end of each supplementation and control period. Serial digoxin plasma concentrations were obtained over 24 h and analyzed by chemiluminescent immunoassay. Comparisons of area under the curve (AUC)((0-3)), AUC((0-24)), C(max,) CL/F, and elimination half-life were used to assess the effects of goldenseal, kava kava, rifampin, and clarithromycin on digoxin pharmacokinetics. Rifampin produced significant reductions (p < 0.01) in AUC((0-3)), AUC((0-24)), CL/F, t(1/2), and C(max), whereas clarithromycin increased these parameters significantly (p < 0.01). With the exception of goldenseal's effect on C(max) (14% increase), no statistically significant effects on digoxin pharmacokinetics were observed following supplementation with either goldenseal or kava kava. When compared with rifampin and clarithromycin, supplementation with these specific formulations of goldenseal or kava kava did not appear to affect digoxin pharmacokinetics, suggesting that these supplements are not potent modulators of P-gp in vivo. 相似文献
4.
Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome 总被引:5,自引:0,他引:5
E Shapiro A K Shapiro G Fulop M Hubbard J Mandeli J Nordlie R A Phillips 《Archives of general psychiatry》1989,46(8):722-730
The results of this controlled study of the treatment of 57 patients with Gilles de la Tourette's syndrome suggested that both haloperidol and pimozide were more effective than placebo, but that haloperidol was slightly more effective than pimozide. Adverse effects occurred more frequently with haloperidol vs placebo than with pimozide vs placebo, but the frequency was not significantly different for haloperidol compared with pimozide. Clinically significant cardiac effects did not occur at a maximum dosage of 0.3 mg/kg or 20 mg/d for pimozide and 10 mg/d for haloperidol. However, the QTc interval was prolonged during pimozide treatment compared with that during haloperidol treatment, although the values for both medications were not in an abnormal range. 相似文献
5.
6.
7.
8.
9.
10.